Elizabeth Bayliss
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chronic Disease | 31 | 2023 | 1655 | 4.720 |
Why?
| Deprescriptions | 9 | 2023 | 24 | 4.350 |
Why?
| Multiple Chronic Conditions | 11 | 2021 | 24 | 3.020 |
Why?
| Dementia | 8 | 2023 | 222 | 2.770 |
Why?
| Primary Health Care | 21 | 2022 | 1619 | 2.580 |
Why?
| Cognitive Dysfunction | 6 | 2023 | 316 | 2.570 |
Why?
| Comorbidity | 23 | 2018 | 1633 | 2.520 |
Why?
| Patient-Centered Care | 8 | 2021 | 509 | 2.150 |
Why?
| Patient Care Team | 9 | 2019 | 528 | 2.120 |
Why?
| Patient Portals | 4 | 2022 | 33 | 1.930 |
Why?
| Delivery of Health Care, Integrated | 6 | 2021 | 246 | 1.540 |
Why?
| Quality of Life | 16 | 2022 | 2453 | 1.500 |
Why?
| Health Status | 8 | 2019 | 797 | 1.480 |
Why?
| Physicians, Primary Care | 7 | 2019 | 246 | 1.440 |
Why?
| Aged | 59 | 2023 | 20705 | 1.420 |
Why?
| Safety-net Providers | 3 | 2021 | 110 | 1.340 |
Why?
| Delivery of Health Care | 8 | 2021 | 855 | 1.270 |
Why?
| Depressive Disorder | 4 | 2012 | 367 | 1.260 |
Why?
| Continuity of Patient Care | 4 | 2019 | 272 | 1.220 |
Why?
| Self Care | 6 | 2012 | 361 | 1.130 |
Why?
| Quality of Health Care | 4 | 2021 | 637 | 1.120 |
Why?
| Aged, 80 and over | 26 | 2023 | 6974 | 1.050 |
Why?
| Chronic Pain | 2 | 2022 | 212 | 1.040 |
Why?
| Mental Disorders | 6 | 2020 | 960 | 1.020 |
Why?
| Communication | 7 | 2022 | 755 | 0.990 |
Why?
| Female | 74 | 2023 | 63903 | 0.980 |
Why?
| Male | 73 | 2023 | 60475 | 0.960 |
Why?
| Health Services | 2 | 2017 | 114 | 0.960 |
Why?
| Attitude of Health Personnel | 5 | 2017 | 1011 | 0.940 |
Why?
| Gastric Bypass | 2 | 2014 | 93 | 0.920 |
Why?
| Humans | 105 | 2023 | 121869 | 0.910 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 2 | 2022 | 242 | 0.910 |
Why?
| Health Status Indicators | 2 | 2014 | 171 | 0.860 |
Why?
| Medication Adherence | 6 | 2022 | 573 | 0.850 |
Why?
| Patient Reported Outcome Measures | 4 | 2019 | 244 | 0.830 |
Why?
| Cholinergic Antagonists | 2 | 2019 | 30 | 0.820 |
Why?
| Retrospective Studies | 29 | 2022 | 13063 | 0.810 |
Why?
| Food Supply | 1 | 2021 | 62 | 0.800 |
Why?
| Health Plan Implementation | 2 | 2019 | 128 | 0.780 |
Why?
| Mental Health Services | 3 | 2019 | 334 | 0.760 |
Why?
| Self Efficacy | 3 | 2019 | 363 | 0.760 |
Why?
| United States | 30 | 2023 | 13209 | 0.750 |
Why?
| Advance Directives | 1 | 2020 | 63 | 0.720 |
Why?
| Qualitative Research | 10 | 2021 | 891 | 0.720 |
Why?
| Medicare Part D | 2 | 2010 | 28 | 0.700 |
Why?
| Cohort Studies | 17 | 2022 | 5300 | 0.690 |
Why?
| Practice Guidelines as Topic | 3 | 2021 | 1511 | 0.670 |
Why?
| Delayed Diagnosis | 1 | 2018 | 83 | 0.660 |
Why?
| Documentation | 1 | 2020 | 181 | 0.660 |
Why?
| Middle Aged | 37 | 2021 | 28961 | 0.650 |
Why?
| Diabetic Neuropathies | 2 | 2016 | 80 | 0.650 |
Why?
| Health Services Needs and Demand | 3 | 2015 | 268 | 0.640 |
Why?
| Hypolipidemic Agents | 3 | 2017 | 88 | 0.640 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1401 | 0.640 |
Why?
| Patient Acceptance of Health Care | 4 | 2021 | 693 | 0.630 |
Why?
| Specialization | 2 | 2017 | 132 | 0.620 |
Why?
| Time-to-Treatment | 1 | 2018 | 161 | 0.620 |
Why?
| Healthcare Disparities | 2 | 2021 | 492 | 0.600 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2023 | 2167 | 0.590 |
Why?
| Health Maintenance Organizations | 6 | 2012 | 109 | 0.580 |
Why?
| Telemedicine | 3 | 2023 | 634 | 0.570 |
Why?
| Patient Satisfaction | 4 | 2019 | 618 | 0.570 |
Why?
| Patients | 2 | 2021 | 138 | 0.570 |
Why?
| Medicaid | 2 | 2022 | 409 | 0.570 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1247 | 0.570 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1225 | 0.560 |
Why?
| Medically Uninsured | 1 | 2017 | 132 | 0.560 |
Why?
| Hypoglycemic Agents | 5 | 2019 | 1033 | 0.550 |
Why?
| Adult | 31 | 2023 | 32683 | 0.550 |
Why?
| Bariatric Surgery | 2 | 2015 | 167 | 0.540 |
Why?
| Colorado | 12 | 2021 | 4344 | 0.540 |
Why?
| Pain Management | 2 | 2015 | 303 | 0.540 |
Why?
| Antihypertensive Agents | 5 | 2019 | 469 | 0.530 |
Why?
| Caregivers | 9 | 2023 | 717 | 0.530 |
Why?
| Health Promotion | 1 | 2021 | 711 | 0.530 |
Why?
| Sickness Impact Profile | 2 | 2005 | 63 | 0.530 |
Why?
| Gastroplasty | 1 | 2014 | 26 | 0.520 |
Why?
| Electronic Health Records | 3 | 2021 | 821 | 0.510 |
Why?
| Surveys and Questionnaires | 17 | 2022 | 4922 | 0.510 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2015 | 114 | 0.500 |
Why?
| Diabetes Mellitus | 7 | 2017 | 960 | 0.500 |
Why?
| Focus Groups | 5 | 2020 | 382 | 0.500 |
Why?
| Health Services Accessibility | 3 | 2017 | 816 | 0.500 |
Why?
| Neuralgia | 1 | 2015 | 109 | 0.490 |
Why?
| Drug Utilization | 2 | 2012 | 180 | 0.480 |
Why?
| Hypertension | 7 | 2019 | 1241 | 0.480 |
Why?
| Postoperative Care | 1 | 2015 | 241 | 0.470 |
Why?
| Laparoscopy | 2 | 2014 | 421 | 0.470 |
Why?
| Hospitalization | 5 | 2022 | 1873 | 0.470 |
Why?
| Morbidity | 2 | 2012 | 300 | 0.470 |
Why?
| Colorectal Neoplasms | 3 | 2014 | 638 | 0.470 |
Why?
| Socioeconomic Factors | 7 | 2020 | 1180 | 0.470 |
Why?
| Comparative Effectiveness Research | 1 | 2014 | 141 | 0.460 |
Why?
| Sleep Deprivation | 1 | 2015 | 182 | 0.460 |
Why?
| Morphine | 1 | 2013 | 141 | 0.440 |
Why?
| Preoperative Care | 1 | 2015 | 344 | 0.440 |
Why?
| Cross-Sectional Studies | 14 | 2023 | 4713 | 0.440 |
Why?
| Osteoarthritis | 3 | 2008 | 177 | 0.430 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2012 | 38 | 0.420 |
Why?
| Referral and Consultation | 1 | 2017 | 680 | 0.420 |
Why?
| Cluster Analysis | 2 | 2020 | 512 | 0.410 |
Why?
| International Classification of Diseases | 1 | 2012 | 124 | 0.400 |
Why?
| Polypharmacy | 5 | 2023 | 76 | 0.400 |
Why?
| Antidepressive Agents | 1 | 2012 | 201 | 0.400 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 403 | 0.400 |
Why?
| Quality Improvement | 5 | 2020 | 996 | 0.390 |
Why?
| Severity of Illness Index | 3 | 2015 | 2876 | 0.390 |
Why?
| Office Visits | 3 | 2018 | 95 | 0.380 |
Why?
| Obesity | 2 | 2014 | 2802 | 0.380 |
Why?
| Psychotherapy | 1 | 2012 | 184 | 0.380 |
Why?
| Self Report | 5 | 2023 | 740 | 0.380 |
Why?
| Physician-Patient Relations | 6 | 2019 | 512 | 0.380 |
Why?
| Prostatic Neoplasms | 2 | 2014 | 1024 | 0.370 |
Why?
| Multimorbidity | 2 | 2021 | 29 | 0.370 |
Why?
| Patient Preference | 3 | 2022 | 172 | 0.370 |
Why?
| Neoplasms | 3 | 2014 | 2241 | 0.370 |
Why?
| Models, Statistical | 1 | 2014 | 676 | 0.360 |
Why?
| Perception | 3 | 2020 | 317 | 0.360 |
Why?
| Vaccination Refusal | 2 | 2021 | 70 | 0.360 |
Why?
| Patient Participation | 5 | 2022 | 371 | 0.360 |
Why?
| Analgesics, Opioid | 2 | 2014 | 781 | 0.360 |
Why?
| Emergency Service, Hospital | 3 | 2015 | 1841 | 0.350 |
Why?
| Stakeholder Participation | 2 | 2020 | 68 | 0.350 |
Why?
| Medicare | 6 | 2023 | 734 | 0.350 |
Why?
| Delphi Technique | 4 | 2018 | 154 | 0.340 |
Why?
| Health Personnel | 3 | 2019 | 572 | 0.340 |
Why?
| Research | 3 | 2018 | 446 | 0.340 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 317 | 0.330 |
Why?
| Risk Assessment | 7 | 2020 | 3248 | 0.330 |
Why?
| Health Services for the Aged | 1 | 2008 | 77 | 0.320 |
Why?
| Geriatrics | 1 | 2008 | 74 | 0.310 |
Why?
| Disease Progression | 2 | 2015 | 2582 | 0.310 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 641 | 0.310 |
Why?
| Cost of Illness | 2 | 2008 | 286 | 0.310 |
Why?
| Breast Neoplasms | 1 | 2018 | 1970 | 0.300 |
Why?
| Kidney Diseases | 1 | 2011 | 427 | 0.290 |
Why?
| Psychometrics | 3 | 2018 | 700 | 0.290 |
Why?
| Accidental Falls | 2 | 2019 | 164 | 0.280 |
Why?
| Potentially Inappropriate Medication List | 2 | 2022 | 11 | 0.280 |
Why?
| Telephone | 2 | 2017 | 161 | 0.270 |
Why?
| Pain Measurement | 2 | 2018 | 484 | 0.260 |
Why?
| Parents | 3 | 2021 | 1255 | 0.250 |
Why?
| Cardiovascular Diseases | 2 | 2014 | 1812 | 0.250 |
Why?
| Patient Compliance | 1 | 2008 | 569 | 0.250 |
Why?
| Nomograms | 2 | 2014 | 52 | 0.250 |
Why?
| Disease Management | 4 | 2017 | 608 | 0.250 |
Why?
| Single-Payer System | 1 | 2003 | 4 | 0.250 |
Why?
| National Health Insurance, United States | 1 | 2003 | 6 | 0.250 |
Why?
| Pragmatic Clinical Trials as Topic | 2 | 2022 | 46 | 0.250 |
Why?
| Death | 2 | 2022 | 114 | 0.240 |
Why?
| Dyslipidemias | 3 | 2019 | 164 | 0.240 |
Why?
| Vaccination | 3 | 2021 | 1218 | 0.240 |
Why?
| Managed Care Programs | 2 | 2014 | 157 | 0.240 |
Why?
| Multivariate Analysis | 5 | 2013 | 1574 | 0.240 |
Why?
| Health Services Research | 3 | 2017 | 379 | 0.230 |
Why?
| Insurance Coverage | 2 | 2018 | 217 | 0.230 |
Why?
| Health Care Reform | 1 | 2003 | 104 | 0.220 |
Why?
| Interdisciplinary Communication | 2 | 2014 | 201 | 0.220 |
Why?
| Attitude | 2 | 2021 | 242 | 0.220 |
Why?
| Data Collection | 1 | 2005 | 677 | 0.220 |
Why?
| Prognosis | 4 | 2014 | 3603 | 0.220 |
Why?
| Asthma | 2 | 2016 | 2130 | 0.220 |
Why?
| Physicians | 2 | 2023 | 791 | 0.220 |
Why?
| Survival Rate | 3 | 2014 | 1828 | 0.210 |
Why?
| Proxy | 1 | 2021 | 23 | 0.200 |
Why?
| Maryland | 1 | 2020 | 41 | 0.200 |
Why?
| Patient Care Management | 1 | 2020 | 59 | 0.190 |
Why?
| Longitudinal Studies | 4 | 2018 | 2652 | 0.190 |
Why?
| Information Storage and Retrieval | 1 | 2021 | 152 | 0.190 |
Why?
| Clergy | 1 | 2020 | 15 | 0.190 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.190 |
Why?
| Age Factors | 6 | 2019 | 3173 | 0.190 |
Why?
| Fee-for-Service Plans | 2 | 2014 | 94 | 0.190 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 170 | 0.190 |
Why?
| Health Surveys | 3 | 2012 | 478 | 0.180 |
Why?
| Southwestern United States | 1 | 2019 | 94 | 0.180 |
Why?
| Residence Characteristics | 1 | 2022 | 315 | 0.180 |
Why?
| Child, Preschool | 5 | 2021 | 9776 | 0.180 |
Why?
| Urban Health Services | 1 | 2019 | 67 | 0.180 |
Why?
| Interprofessional Relations | 2 | 2013 | 267 | 0.180 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.180 |
Why?
| Follow-Up Studies | 4 | 2017 | 4883 | 0.180 |
Why?
| Religion | 1 | 2019 | 73 | 0.170 |
Why?
| Comprehensive Health Care | 2 | 2017 | 21 | 0.170 |
Why?
| Attitude to Health | 2 | 2015 | 417 | 0.170 |
Why?
| Time Factors | 5 | 2018 | 6889 | 0.170 |
Why?
| Contraindications, Drug | 1 | 2018 | 8 | 0.170 |
Why?
| Mastectomy | 1 | 2018 | 126 | 0.160 |
Why?
| Radiotherapy, Adjuvant | 1 | 2018 | 191 | 0.160 |
Why?
| Vaccines | 2 | 2020 | 371 | 0.160 |
Why?
| Interviews as Topic | 3 | 2016 | 604 | 0.160 |
Why?
| Medical Informatics | 1 | 2019 | 110 | 0.160 |
Why?
| Young Adult | 6 | 2016 | 11223 | 0.160 |
Why?
| Chemotherapy, Adjuvant | 1 | 2018 | 363 | 0.160 |
Why?
| Prospective Studies | 5 | 2023 | 6629 | 0.160 |
Why?
| Independent Living | 1 | 2018 | 86 | 0.150 |
Why?
| Models, Theoretical | 1 | 2021 | 595 | 0.150 |
Why?
| SEER Program | 2 | 2014 | 205 | 0.150 |
Why?
| General Practice | 1 | 2016 | 26 | 0.150 |
Why?
| Case Management | 1 | 2017 | 66 | 0.150 |
Why?
| Electronics | 1 | 2017 | 76 | 0.150 |
Why?
| Logistic Models | 5 | 2013 | 2037 | 0.140 |
Why?
| Blood Pressure | 3 | 2019 | 1717 | 0.140 |
Why?
| Adolescent | 6 | 2015 | 19126 | 0.140 |
Why?
| Influenza Vaccines | 1 | 2021 | 496 | 0.140 |
Why?
| Medication Therapy Management | 1 | 2017 | 76 | 0.140 |
Why?
| Body Mass Index | 2 | 2014 | 2174 | 0.140 |
Why?
| Schools | 1 | 2019 | 426 | 0.140 |
Why?
| Patient Outcome Assessment | 1 | 2017 | 135 | 0.140 |
Why?
| Validation Studies as Topic | 1 | 2015 | 22 | 0.140 |
Why?
| Health Care Costs | 1 | 2019 | 411 | 0.140 |
Why?
| Metformin | 1 | 2019 | 301 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2018 | 287 | 0.130 |
Why?
| Influenza, Human | 1 | 2021 | 556 | 0.130 |
Why?
| Infant | 2 | 2021 | 8440 | 0.130 |
Why?
| Neoplasm Staging | 1 | 2018 | 1237 | 0.130 |
Why?
| Hyperlipidemias | 2 | 2012 | 136 | 0.130 |
Why?
| United States Agency for Healthcare Research and Quality | 1 | 2014 | 10 | 0.130 |
Why?
| Proportional Hazards Models | 2 | 2015 | 1190 | 0.120 |
Why?
| Child | 5 | 2021 | 19282 | 0.120 |
Why?
| Research Design | 1 | 2020 | 1003 | 0.120 |
Why?
| Health Priorities | 1 | 2014 | 36 | 0.120 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2022 | 764 | 0.120 |
Why?
| Activities of Daily Living | 2 | 2008 | 378 | 0.120 |
Why?
| Health Education | 1 | 2016 | 328 | 0.120 |
Why?
| Cooperative Behavior | 2 | 2014 | 414 | 0.120 |
Why?
| Age Distribution | 1 | 2014 | 386 | 0.120 |
Why?
| Decision Making | 1 | 2019 | 825 | 0.110 |
Why?
| Risk Factors | 6 | 2023 | 9419 | 0.110 |
Why?
| Lung Diseases, Obstructive | 1 | 2012 | 50 | 0.110 |
Why?
| Terminally Ill | 1 | 2013 | 40 | 0.110 |
Why?
| Postoperative Complications | 2 | 2014 | 2322 | 0.110 |
Why?
| Postoperative Period | 1 | 2013 | 323 | 0.110 |
Why?
| Depression | 3 | 2018 | 1201 | 0.110 |
Why?
| Guideline Adherence | 1 | 2017 | 552 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 876 | 0.110 |
Why?
| Information Dissemination | 1 | 2014 | 220 | 0.110 |
Why?
| Obesity, Morbid | 1 | 2014 | 202 | 0.100 |
Why?
| Insulin | 2 | 2019 | 2156 | 0.100 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 363 | 0.100 |
Why?
| Secondary Prevention | 1 | 2013 | 251 | 0.100 |
Why?
| Diabetes Complications | 1 | 2013 | 222 | 0.100 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 130 | 0.100 |
Why?
| Primary Prevention | 1 | 2013 | 212 | 0.100 |
Why?
| Data Mining | 1 | 2011 | 139 | 0.090 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 115 | 0.090 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 228 | 0.090 |
Why?
| Weight Loss | 1 | 2015 | 736 | 0.090 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 739 | 0.090 |
Why?
| Databases, Factual | 2 | 2012 | 1285 | 0.090 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2013 | 248 | 0.090 |
Why?
| Prescription Fees | 1 | 2008 | 3 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 2999 | 0.090 |
Why?
| Medical Records Systems, Computerized | 2 | 2007 | 91 | 0.090 |
Why?
| Autoimmune Diseases | 1 | 2012 | 400 | 0.090 |
Why?
| Poisson Distribution | 1 | 2008 | 74 | 0.080 |
Why?
| Self Disclosure | 1 | 2008 | 63 | 0.080 |
Why?
| Eligibility Determination | 1 | 2008 | 54 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2008 | 66 | 0.080 |
Why?
| Pain | 1 | 2014 | 745 | 0.080 |
Why?
| Community Health Services | 1 | 2010 | 214 | 0.080 |
Why?
| Treatment Outcome | 4 | 2016 | 9654 | 0.080 |
Why?
| Incidence | 2 | 2014 | 2520 | 0.080 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.080 |
Why?
| Immunoglobulin G | 1 | 2012 | 792 | 0.080 |
Why?
| Biomedical Research | 1 | 2014 | 632 | 0.080 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 405 | 0.080 |
Why?
| Treatment Refusal | 1 | 2007 | 92 | 0.080 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3347 | 0.070 |
Why?
| Sex Distribution | 1 | 2007 | 374 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 1052 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2012 | 706 | 0.070 |
Why?
| Mass Screening | 1 | 2013 | 1089 | 0.070 |
Why?
| Urban Population | 2 | 2012 | 433 | 0.070 |
Why?
| California | 2 | 2020 | 386 | 0.070 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1289 | 0.070 |
Why?
| Chicago | 1 | 2004 | 45 | 0.060 |
Why?
| Los Angeles | 1 | 2004 | 62 | 0.060 |
Why?
| Linear Models | 1 | 2007 | 886 | 0.060 |
Why?
| Boston | 1 | 2004 | 78 | 0.060 |
Why?
| Pandemics | 2 | 2023 | 1316 | 0.060 |
Why?
| Self Concept | 1 | 2005 | 224 | 0.060 |
Why?
| Goals | 1 | 2005 | 169 | 0.060 |
Why?
| Social Support | 1 | 2007 | 558 | 0.060 |
Why?
| Algorithms | 1 | 2011 | 1618 | 0.060 |
Why?
| Choice Behavior | 1 | 2005 | 178 | 0.060 |
Why?
| Medicine | 1 | 2004 | 106 | 0.060 |
Why?
| Regression Analysis | 1 | 2004 | 1049 | 0.050 |
Why?
| Cholesterol, LDL | 2 | 2014 | 319 | 0.050 |
Why?
| Insurance Claim Review | 1 | 2021 | 68 | 0.050 |
Why?
| Washington | 1 | 2021 | 137 | 0.050 |
Why?
| Housing | 1 | 2022 | 118 | 0.050 |
Why?
| Internet | 2 | 2019 | 698 | 0.050 |
Why?
| Health Care Rationing | 1 | 2020 | 53 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2012 | 564 | 0.050 |
Why?
| Resource Allocation | 1 | 2020 | 40 | 0.050 |
Why?
| Health Expenditures | 1 | 2022 | 195 | 0.050 |
Why?
| Assisted Living Facilities | 1 | 2020 | 11 | 0.050 |
Why?
| Medical Records | 1 | 2021 | 181 | 0.050 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 121 | 0.050 |
Why?
| Minority Groups | 1 | 2022 | 248 | 0.050 |
Why?
| Social Determinants of Health | 1 | 2021 | 137 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 2142 | 0.040 |
Why?
| Health Behavior | 1 | 2005 | 745 | 0.040 |
Why?
| Medicare Part C | 1 | 2019 | 21 | 0.040 |
Why?
| Nursing Homes | 1 | 2020 | 146 | 0.040 |
Why?
| Appointments and Schedules | 1 | 2019 | 81 | 0.040 |
Why?
| Mortality | 1 | 2020 | 325 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 1067 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 804 | 0.040 |
Why?
| Intention | 1 | 2019 | 152 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 298 | 0.040 |
Why?
| Fatigue | 1 | 2018 | 317 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 1003 | 0.040 |
Why?
| Automation | 1 | 2016 | 79 | 0.040 |
Why?
| Drug Interactions | 1 | 2017 | 368 | 0.030 |
Why?
| Guidelines as Topic | 1 | 2018 | 272 | 0.030 |
Why?
| Consensus | 1 | 2018 | 537 | 0.030 |
Why?
| Prevalence | 1 | 2022 | 2444 | 0.030 |
Why?
| Hospitals | 1 | 2020 | 598 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 560 | 0.030 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 306 | 0.030 |
Why?
| Patient Access to Records | 1 | 2013 | 19 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 496 | 0.030 |
Why?
| Analysis of Variance | 2 | 2007 | 1383 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 553 | 0.030 |
Why?
| Electronic Mail | 1 | 2013 | 59 | 0.030 |
Why?
| Remote Consultation | 1 | 2013 | 40 | 0.030 |
Why?
| Turkey | 1 | 2012 | 16 | 0.030 |
Why?
| Etanercept | 1 | 2012 | 51 | 0.030 |
Why?
| London | 1 | 2012 | 47 | 0.030 |
Why?
| Biomarkers | 2 | 2013 | 3652 | 0.030 |
Why?
| Infliximab | 1 | 2012 | 93 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 873 | 0.030 |
Why?
| Forecasting | 1 | 2014 | 382 | 0.030 |
Why?
| Needs Assessment | 1 | 2014 | 348 | 0.030 |
Why?
| Cross-Cultural Comparison | 1 | 2012 | 82 | 0.030 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 148 | 0.030 |
Why?
| United Kingdom | 1 | 2012 | 254 | 0.030 |
Why?
| Reoperation | 1 | 2013 | 578 | 0.020 |
Why?
| Immunologic Factors | 1 | 2012 | 229 | 0.020 |
Why?
| Antirheumatic Agents | 1 | 2012 | 247 | 0.020 |
Why?
| Models, Organizational | 1 | 2010 | 148 | 0.020 |
Why?
| Risk | 1 | 2012 | 925 | 0.020 |
Why?
| Sex Characteristics | 1 | 2014 | 700 | 0.020 |
Why?
| Empathy | 1 | 2010 | 143 | 0.020 |
Why?
| Aging | 1 | 2018 | 1692 | 0.020 |
Why?
| Holistic Health | 1 | 2007 | 6 | 0.020 |
Why?
| Patient Readmission | 1 | 2013 | 678 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1176 | 0.020 |
Why?
| Veterans | 1 | 2017 | 1148 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1898 | 0.020 |
Why?
| Learning | 1 | 2010 | 397 | 0.020 |
Why?
| CD-ROM | 1 | 2005 | 7 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2005 | 76 | 0.020 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 67 | 0.020 |
Why?
| Nonlinear Dynamics | 1 | 2005 | 96 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 148 | 0.020 |
Why?
| Fruit | 1 | 2005 | 130 | 0.020 |
Why?
| Registries | 1 | 2012 | 1956 | 0.020 |
Why?
| Vegetables | 1 | 2005 | 133 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2005 | 720 | 0.010 |
Why?
| Exercise | 1 | 2005 | 1866 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|